Roivant Splashes Cash Again To License GSK Skin Disorder Drug

 
• By Kevin Grogan
  
Gold
Riches under the Roivant umbrella • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapeutic Category